PPT-Quality Issues for Clinical Trial Materials
Author : min-jolicoeur | Published Date : 2018-11-21
The Chemistry Manufacturing and Controls CMC Review Dorota Matecka PhD Office of Pharmaceutical Quality OPQ CDER Outline Pharmaceutical Quality CMC Requirements
Presentation Embed Code
Download Presentation
Download Presentation The PPT/PDF document "Quality Issues for Clinical Trial Materi..." is the property of its rightful owner. Permission is granted to download and print the materials on this website for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.
Quality Issues for Clinical Trial Materials: Transcript
The Chemistry Manufacturing and Controls CMC Review Dorota Matecka PhD Office of Pharmaceutical Quality OPQ CDER Outline Pharmaceutical Quality CMC Requirements for INDs CMC Safety Concerns. The Balance from . A Medical Communicator’s Perspective. 6th Asia-Pacific . Pharma. Congress. July 11-13, 2016 Kuala Lumpur, Malaysia. Dr.Namrata. Singh. Director - Medical Services. Turcaoz. Health Care Solutions. CLINICAL TRIALS IN THE TWENTY-FIRST CENTURY: ONGOING CHALLENGES AND EMERGING ISSUES Susan S. Ellenberg , Ph.D. University of Pennsylvania SCT/ICTMC Joint Meeting Liverpool, UK May 8, 2017 CLINICAL TRIALS TIMELINE Industry and CRO Perspective on Clinical Trial Quality David J. Hewitt Vice President of Medical and Scientific Affairs Vice President and Global Head MSA Neurology and Pain IMMPACT June 2015 Currently working for inVentiv Health a CRO/CCO Susan S. . Ellenberg. , Ph.D.. University of Pennsylvania. SCT/ICTMC Joint Meeting. Liverpool, UK. May 8, 2017. CLINICAL TRIALS TIMELINE. 1948: First randomized clinical trials of modern era. 1962: Amendments to U.S. Food, Drug and Cosmetic Act requiring demonstration of efficacy as well as safety. . SYFTET. Göteborgs universitet ska skapa en modern, lättanvänd och . effektiv webbmiljö med fokus på användarnas förväntningar.. 1. ETT UNIVERSITET – EN GEMENSAM WEBB. Innehåll som är intressant för de prioriterade målgrupperna samlas på ett ställe till exempel:. Barry R. Davis, MD, PhD. University of Texas School of Public Health. Houston, TX. Duke Industry Statistics Symposium . A. re Pragmatic Trials Ready for Prime Time?. September 7, 2017. Outline. Description of . Unblinding. and Termination. Within-trial . decisions . are decisions that need to be made once a . clinical trial. has already . started, . for example, if there is an . unexpected . problem. . These . T. he . trial sponsor . compiles . a detailed clinical study report (CSR. ) after each clinical trial. . This report follows . a format laid down by the regulatory . authorities.. The CSR can be hundreds of pages long.. Collecting data. 2. Data . Statistics is a way of thinking—thinking about ways to . gather. and analyze data.. Trust data. 3. 3. Resource of Data. Experiment/ clinical trial. Survey. http://www.nhs.uk/Conditions/Clinical-trials/Pages/Healthresearch.aspx. What is the Patient Engagement Open Forum. A series of virtual events (in 2020) where we will work together, in a multi-stakeholder context, . to turn patient engagement into reality. .. The Forum aims to provide . Tony Durkee, PhD. Coordinator for Clinical Trial Reporting. Compliance & Data Office (CDO), Research Support Office (RSO). Karolinska . Institutet. (KI). Email: tony.durkee@ki.se. . 6/17/2021. Tony Durkee. Lalitha K. Shankar, MD, PhD,. Cancer Imaging Program, NCI. March 26, 2018. NCI Planning Committee. Jeff Abrams, Barry Kramer, Paul Jacobsen (DCTD, DCP & DCCPS) . Lalitha Shankar, Bhupinder Mann, Carmen Allegra, Shakuntala Malik, Larissa Korde, Nita Seibel, Worta McCaskill-Stevens and Anne Menkens. B. rain . I. njury . T. reatment Trial: A Multicenter Phase II Adaptive Clinical Trial. . Gaylan. . Rockswold. , MD, PhD, Principal Investigator. Thomas Bergman, MD, Site Principal Investigator. Overview. A Feasibility Study. SciSIP. PI Conference, September 2012. Ernst R. Berndt. Iain M. Cockburn. MIT, Boston University, and . National Bureau of Economic Research. What?. Analysis of trends in costs of doing clinical trials.
Download Document
Here is the link to download the presentation.
"Quality Issues for Clinical Trial Materials"The content belongs to its owner. You may download and print it for personal use, without modification, and keep all copyright notices. By downloading, you agree to these terms.
Related Documents
